Biovian brings one stop shop to BIO-Europe Paris
Press Release | Biovian Ltd
MARCH 07, 2015
Turku, Finland: – Specialist biopharmaceutical CMO Biovian will once again field a high powered team at next week’s BIO-Europe Spring event in Paris.
Biovian CEO Dr. Knut Ringbom will lead the Finnish-based manufacturer’s presence at BIO-Europe. He will be available for one-to-one meetings and to share news of latest developments in Biovian’s distinctive “gene to finished vial“ end-to-end cGMP service.
Dr. Ringbom will also be available via the conference’s web-based partnering ONE system to set up in-depth discussions on biopharma research or manufacturing projects that require the Finnish contract manufacturer’s extensive range of cGMP manufacturing and development services.
“We are delighted to be returning to BIO-Europe, which is one of our favourite events,” said Dr. Ringbom.
“We regularly attend this event, most recently in Frankfurt last November, where we enjoyed a very successful show,” he explained.
One stop shop
“The audience and agenda at the BIO-Europe events are ideal for our company and we usually meet many of our existing customers here, as well as potential new partners,” said the Biovian CEO.
“Always they’re impressed when we show the broad range of our capabilities that have turned Biovian into a genuine ‘one stop shop’ CMO for cGMP biopharmaceutical manufacturing.”
“Via the online partnering system, we will be available to provide in-depth information on our biopharmaceutical manufacturing facilities and latest developments,” Dr. Ringbom added.
Biovian Ltd. is a one-stop-shop Contract Manufacturing Organization (CMO) specializing in full-process development and manufacture that extends ‘from gene to finished vial’.
Biovian offers Good Manufacturing Practice compliant (cGMP) services from its 2,300 square meter facilities in Turku, Finland, that are EMA and FDA certified for production of investigational and commercial products.
The CMO has more than a decade’s successful track record in pharmaceutical contract manufacturing ranging over a wide variety of different biopharmaceutical projects. Biovian GMP services include microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish, analytical quality control, stability studies and master cell banking. It also offers labeling, packaging, storage and QP release services.
Biovian also provides development services that cover cell line, process and analysis.
About BIO-Europe Spring 2015
The BIO-Europe Spring® Conference is the springtime counterpart to EBD Group’s flagship conference BIO-Europe®, providing life science companies with further high caliber knowledge sharing and partnering opportunities.
The 2014 Bio-Europe Spring event is being held on March 9-11 at the Paris Expo Centre in Porte de Versailles.
The BIO-Europe partnering conferences have been running since 2006 and consistently attract top international executives from established and emerging pharma and biotech companies, along with academic researchers and private investors including venture capital and private equity and organizations developing companion diagnostics.
More than 3,000 people attended the 2014 Bio Europe event last autumn in Frankfurt, representing some 1,800 companies and organizations from 56 countries, along with 95 exhibitors. The 2014 event also featured more than 180 presentations and 18 workshops or panels.
The event is organised by EBD Group, whose sophisticated web-based partneringONE system was last year used to facilitate almost 18,000 one-to-one meetings, with some 3,600 licensing opportunities posted.
More information at: http://www.ebdgroup.com/bes/index.php
Name: Dr. Knut Ringbom, CEO, Biovian Ltd.
Tel: +35 82 274 8877